ATE439841T1 - Pharmazeutische zusammensetzungen mit zd6474 - Google Patents

Pharmazeutische zusammensetzungen mit zd6474

Info

Publication number: ATE439841T1
Authority: AT; Austria
Prior art keywords: pharmaceutical compositions; compositions containing; pharmaceutical; compositions
Prior art date: 2004-05-21

Application number

AT05744858T

Other languages

English (en)

Inventor

Paul William Stott

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-05-21

Filing date

2005-05-18

Publication date

2009-09-15

2005-05-18 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2009-09-15 Application granted granted Critical

2009-09-15 Publication of ATE439841T1 publication Critical patent/ATE439841T1/de

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Cardiology (AREA)
Hematology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Plural Heterocyclic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Steroid Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT05744858T 2004-05-21 2005-05-18 Pharmazeutische zusammensetzungen mit zd6474 ATE439841T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0411378.3A GB0411378D0 (en)	2004-05-21	2004-05-21	Pharmaceutical compositions
PCT/GB2005/001931 WO2005112934A1 (en)	2004-05-21	2005-05-18	Pharmaceutical compositions comprising zd6474

Publications (1)

Publication Number	Publication Date
ATE439841T1 true ATE439841T1 (de)	2009-09-15

Family

ID=32607743

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT05744858T ATE439841T1 (de)	2004-05-21	2005-05-18	Pharmazeutische zusammensetzungen mit zd6474

Country Status (34)

Country	Link
US (1)	US8067427B2 (de)
EP (1)	EP1753431B1 (de)
JP (1)	JP4740947B2 (de)
KR (1)	KR101192935B1 (de)
CN (1)	CN101031303B (de)
AR (2)	AR049059A1 (de)
AT (1)	ATE439841T1 (de)
AU (1)	AU2005244650B2 (de)
BR (1)	BRPI0511253B8 (de)
CA (1)	CA2565513C (de)
CY (1)	CY1109500T1 (de)
DE (1)	DE602005016105D1 (de)
DK (1)	DK1753431T3 (de)
ES (1)	ES2330025T3 (de)
GB (1)	GB0411378D0 (de)
HK (1)	HK1099220A1 (de)
HR (1)	HRP20090547T1 (de)
IL (1)	IL178928A (de)
ME (2)	ME01505B (de)
MX (1)	MXPA06013501A (de)
MY (1)	MY138868A (de)
NO (1)	NO338324B1 (de)
NZ (1)	NZ550931A (de)
PL (1)	PL1753431T3 (de)
PT (1)	PT1753431E (de)
RS (1)	RS51112B (de)
RU (1)	RU2383343C2 (de)
SA (1)	SA05260133B1 (de)
SI (1)	SI1753431T1 (de)
TW (1)	TWI355269B (de)
UA (1)	UA81732C2 (de)
UY (1)	UY28901A1 (de)
WO (1)	WO2005112934A1 (de)
ZA (1)	ZA200609110B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2278511B1 (es) *	2005-07-28	2008-06-16	Laboratorios Almirall S.A.	Comprimidos con perfil de disolucion mejorado.
DK3039424T3 (da)	2013-08-28	2020-08-31	Crown Bioscience Inc Taicang	Genekspressionssignaturer, der er prædiktive for et individs respons på en multikinaseinhibitor, og fremgangsmåder til anvendelse af disse

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9718972D0 (en) *	1996-09-25	1997-11-12	Zeneca Ltd	Chemical compounds
EP1676845B1 (de)	1999-11-05	2008-06-11	AstraZeneca AB	Neue Quinazolin-Derivate
GB0001621D0 (en) *	2000-01-26	2000-03-15	Astrazeneca Ab	Pharmaceutical compositions
KR100419555B1 (ko) *	2000-05-29	2004-02-19	주식회사유한양행	비형간염바이러스의 에스-표면항원을 인식하는단일클론항체의 가변영역 및 이를 코딩하는 유전자
AU2003211594A1 (en)	2002-03-05	2003-09-16	Eisai Co., Ltd.	Antitumor agent comprising combination of sulfonamide-containing heterocyclic compound with angiogenesis inhibitor

2004
- 2004-05-21 GB GBGB0411378.3A patent/GB0411378D0/en not_active Ceased
2005
- 2005-05-09 TW TW094114935A patent/TWI355269B/zh active
- 2005-05-17 UY UY28901A patent/UY28901A1/es unknown
- 2005-05-18 EP EP05744858A patent/EP1753431B1/de active Active
- 2005-05-18 BR BRPI0511253A patent/BRPI0511253B8/pt active IP Right Grant
- 2005-05-18 ES ES05744858T patent/ES2330025T3/es active Active
- 2005-05-18 RU RU2006145357/15A patent/RU2383343C2/ru active Protection Beyond IP Right Term
- 2005-05-18 SA SA05260133A patent/SA05260133B1/ar unknown
- 2005-05-18 RS RSP-2009/0458A patent/RS51112B/sr unknown
- 2005-05-18 NZ NZ550931A patent/NZ550931A/en not_active IP Right Cessation
- 2005-05-18 ME MEP-2013-50A patent/ME01505B/me unknown
- 2005-05-18 CN CN2005800162448A patent/CN101031303B/zh active Active
- 2005-05-18 ME MEP-2009-458A patent/ME02778B/me unknown
- 2005-05-18 WO PCT/GB2005/001931 patent/WO2005112934A1/en active Application Filing
- 2005-05-18 PT PT05744858T patent/PT1753431E/pt unknown
- 2005-05-18 AU AU2005244650A patent/AU2005244650B2/en active Active
- 2005-05-18 UA UAA200613289A patent/UA81732C2/ru unknown
- 2005-05-18 CA CA2565513A patent/CA2565513C/en active Active
- 2005-05-18 AT AT05744858T patent/ATE439841T1/de active
- 2005-05-18 JP JP2007517415A patent/JP4740947B2/ja active Active
- 2005-05-18 MX MXPA06013501A patent/MXPA06013501A/es active IP Right Grant
- 2005-05-18 DK DK05744858T patent/DK1753431T3/da active
- 2005-05-18 KR KR1020067026603A patent/KR101192935B1/ko active IP Right Grant
- 2005-05-18 SI SI200530793T patent/SI1753431T1/sl unknown
- 2005-05-18 US US11/596,979 patent/US8067427B2/en active Active
- 2005-05-18 DE DE602005016105T patent/DE602005016105D1/de active Active
- 2005-05-18 PL PL05744858T patent/PL1753431T3/pl unknown
- 2005-05-19 MY MYPI20052271A patent/MY138868A/en unknown
- 2005-05-20 AR ARP050102087A patent/AR049059A1/es not_active Application Discontinuation
2006
- 2006-10-29 IL IL178928A patent/IL178928A/en active IP Right Grant
- 2006-11-01 ZA ZA200609110A patent/ZA200609110B/en unknown
- 2006-12-12 NO NO20065735A patent/NO338324B1/no not_active IP Right Cessation
2007
- 2007-06-13 HK HK07106372.8A patent/HK1099220A1/xx unknown
2009
- 2009-10-13 HR HR20090547T patent/HRP20090547T1/xx unknown
- 2009-10-15 CY CY20091101075T patent/CY1109500T1/el unknown
2017
- 2017-11-09 AR ARP170103128A patent/AR110045A2/es unknown

Also Published As

Publication number	Publication date
KR20070034499A (ko)	2007-03-28
CA2565513C (en)	2010-10-19
DE602005016105D1 (de)	2009-10-01
HRP20090547T1 (en)	2009-11-30
MY138868A (en)	2009-08-28
IL178928A (en)	2012-04-30
KR101192935B1 (ko)	2012-10-18
BRPI0511253A (pt)	2007-11-27
JP4740947B2 (ja)	2011-08-03
ME02778B (me)	2010-10-31
AR110045A2 (es)	2019-02-20
WO2005112934A1 (en)	2005-12-01
NZ550931A (en)	2009-05-31
ES2330025T3 (es)	2009-12-03
CA2565513A1 (en)	2005-12-01
EP1753431B1 (de)	2009-08-19
NO338324B1 (no)	2016-08-08
CN101031303B (zh)	2011-08-31
AU2005244650A1 (en)	2005-12-01
US8067427B2 (en)	2011-11-29
MXPA06013501A (es)	2007-06-12
TW200612953A (en)	2006-05-01
CN101031303A (zh)	2007-09-05
CY1109500T1 (el)	2014-08-13
SA05260133B1 (ar)	2008-12-23
US20070244323A1 (en)	2007-10-18
RS51112B (sr)	2010-10-31
GB0411378D0 (en)	2004-06-23
HK1099220A1 (en)	2007-08-10
TWI355269B (en)	2012-01-01
PT1753431E (pt)	2009-10-14
RU2006145357A (ru)	2008-06-27
JP2007538060A (ja)	2007-12-27
IL178928A0 (en)	2007-03-08
BRPI0511253B8 (pt)	2021-05-25
NO20065735L (no)	2006-12-19
AU2005244650B2 (en)	2008-04-10
UY28901A1 (es)	2005-12-30
AR049059A1 (es)	2006-06-21
SI1753431T1 (sl)	2009-12-31
UA81732C2 (ru)	2008-01-25
PL1753431T3 (pl)	2009-12-31
DK1753431T3 (da)	2009-11-16
EP1753431A1 (de)	2007-02-21
ME01505B (me)	2014-04-20
ZA200609110B (en)	2008-06-25
BRPI0511253B1 (pt)	2020-03-31
RU2383343C2 (ru)	2010-03-10

Publication	Publication Date	Title
BRPI0511900A (pt)	2008-01-22	composições farmacêuticas
ITBO20050123A1 (it)	2005-06-06	Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
ATE489078T1 (de)	2010-12-15	Pharmazeutische zusammensetzungen mit rosuvastatin-calcium
IL177480A0 (en)	2006-12-10	Pharmaceutical composition
IL179933A0 (en)	2007-05-15	Pharmaceutical compositions containing proteosome based compositions
DK1587478T3 (da)	2013-10-21	Farmaceutisk sammensætning
DK2783682T3 (da)	2019-08-12	Farmaceutisk sammensætning omfattende pimobendan
DK3072507T3 (da)	2021-02-08	Farmaceutiske sammensætninger til glukokortikoidsubstitutionsterapi
ATE480227T1 (de)	2010-09-15	Pharmazeutische zusammensetzungen mit quetiapinfumarat
ATE448780T1 (de)	2009-12-15	Pharmazeutische modafinil-zusammensetzungen mit modifizierter freisetzung
MA28603B1 (fr)	2007-05-02	Composition pharmaceutique antimycobacterienne
HU0401177D0 (en)	2004-08-30	Pharmaceutical composition
GB2411355B (en)	2006-02-22	Pharmaceutical composition
ATE486633T1 (de)	2010-11-15	Feste pharmazeutische zusammensetzung mit telithromycin
DK2918286T3 (da)	2020-03-30	En farmaceutisk formulering
ATE489943T1 (de)	2010-12-15	Pharmazeutische zusammensetzung mit 2,3-dihydro-6-nitroimidazoä2,1-büoxazolderivate
ZA200701932B (en)	2008-08-27	Pharmaceutical composition
GB0425255D0 (en)	2004-12-15	Pharmaceutical composition
ITMI20041447A1 (it)	2004-10-20	Composizione farmaceutica comprendente gabapentina
ITMI20040943A1 (it)	2004-08-11	Composizione farmaceutica cicatrizzante
ZA200701931B (en)	2008-10-29	Pharmaceutical composition
ATE439841T1 (de)	2009-09-15	Pharmazeutische zusammensetzungen mit zd6474
DE602005005033D1 (de)	2008-04-10	Sprühgetrocknete pharmazeutische zusammensetzungen
ATE428416T1 (de)	2009-05-15	Feste pharmazeutische zubereitung enthaltend (r)- (-)-2-ä5-(4-fluorophenyl)-3- pyridylmethylaminomethylü-chroman
DE602004030921D1 (de)	2011-02-17	Pharmazeutische zusammensetzung

Legal Events

Date	Code	Title	Description
2010-03-15	UEP	Publication of translation of european patent specification	Ref document number: 1753431 Country of ref document: EP

Date

Code

Title

Description

2010-03-15

UEP

Publication of translation of european patent specification

Ref document number: 1753431

Country of ref document: EP